Gilead announced Tuesday that it will soon begin a Phase 3 trial of a drug that could prevent HIV infection with a single annual shot. If...
The Institute for Health Metrics and Evaluation (IHME) has published a new study. Lancet HIV The journal highlights important progress in the global fight against HIV/AIDS...
NEW YORK – The decline in drug overdose deaths in the United States appears to have continued this year, with experts hopeful of sustained improvement in...
HealthDay News—For adolescent girls and young women, a dose of lenacapavir given every 26 weeks is effective in preventing acquired HIV infection, according to a study...
A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates. Providing more...
NEW YORK — Friday marked the 35th annual World AIDS Day, when every Dec. 1 people gather to remember those who have died of and been...
Recent Comments